APPROVED BY SALUS IRB: 13 SEPTEMBER 2021Informed Consent Document • September 21st, 2021
Contract Type FiledSeptember 21st, 2021You are being invited to take part in an “actual use” research study. Before you decide to take part in this study, you should read this document. This document, called an informed consent document, explains the study. Please do not hesitate to ask questions.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • August 26th, 2022
Contract Type FiledAugust 26th, 2022You are here today as a possible participant in a drug research study sponsored by Pfizer Inc. Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • July 1st, 2021
Contract Type FiledJuly 1st, 2021You are here today as a possible participant in a drug research study sponsored by Pfizer Inc. Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • April 2nd, 2024
Contract Type FiledApril 2nd, 2024You are here today as a possible participant in a drug research study sponsored by Pfizer Inc. Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
AGREEMENT TO BE IN A RESEARCH STUDY FOR PARTICIPANTS WITH OBESITY - PART D ONLYInformed Consent Document • March 28th, 2024
Contract Type FiledMarch 28th, 2024You are here today as a possible participant in a drug research study sponsored by Pfizer Inc. Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • March 29th, 2023
Contract Type FiledMarch 29th, 2023You are here today as a possible participant in a drug research study sponsored by Pfizer Inc. Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • January 27th, 2022
Contract Type FiledJanuary 27th, 2022You are here today as a possible participant in a drug research study sponsored by Pfizer Inc. Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
APPROVED BY SALUS IRB: 08 OCTOBER 2020Informed Consent Document • October 9th, 2020
Contract Type FiledOctober 9th, 2020A digital health trial that assesses participant-driven data collection using smartphone modules to characterize myasthenia gravis symptoms and develop an A.I. model to predict flares
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIVInformed Consent Document • December 20th, 2023
Contract Type FiledDecember 20th, 2023
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • July 29th, 2024
Contract Type FiledJuly 29th, 2024OF STUDY: BP-C-19010; “A Randomized, Three-Sequence, Three- Period Crossover Study to Assess the Bioavailability and Pharmacokinetics of a Single Dose of Atropine Administered Sublingually in Healthy Adult Volunteers”
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • November 30th, 2022
Contract Type FiledNovember 30th, 2022You are here today as a possible participant in a drug research study sponsored by Pfizer Inc and Arvinas Estrogen Receptor, Inc. (Arvinas). Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • November 12th, 2022
Contract Type FiledNovember 12th, 2022
AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • December 11th, 2017
Contract Type FiledDecember 11th, 2017NAME OF STUDY: Comparative Study of the OCT-HS100 with OCT Angiography and the RTVue XR OCT with Avanti with AngioVue Software
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • November 14th, 2019
Contract Type FiledNovember 14th, 2019Double-Blind, Single and Multiple Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects”
AN AGREEMENT TO BE IN A RESEARCH STUDY INFORMED CONSENT DOCUMENTInformed Consent Document • October 28th, 2021
Contract Type FiledOctober 28th, 2021You are being invited to take part in a medical research study. Before you decide to take part in this study, you should read this document. This document, called an informed consent document, explains the study. Please ask as many questions as needed so that you can decide if you want to be in the study.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • February 9th, 2021
Contract Type FiledFebruary 9th, 2021DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO CONTROLLED, SINGLE- AND MULTIPLE-DOSE ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF PF-07321332 IN HEALTHY ADULT PARTICIPANTS”
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • March 22nd, 2024
Contract Type FiledMarch 22nd, 2024You are here today as a possible participant in a vaccine research study sponsored by Pfizer Inc. Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
APPROVED BY INTEGREVIEW IRB MAY 26, 2020Informed Consent Document • September 1st, 2022
Contract Type FiledSeptember 1st, 2022
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • October 21st, 2024
Contract Type FiledOctober 21st, 2024You are here today as a possible participant in a drug research study sponsored by Pfizer Inc. Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • December 11th, 2020
Contract Type FiledDecember 11th, 2020You are deciding if you would like to volunteer for a medical research study. You must read and sign this form before you agree to take part in this study. This form will give you more information about this study. Please ask as many questions as you need to before you decide if you want to be in the study. You should not sign this form if you have any questions that have not been answered.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • April 13th, 2021
Contract Type FiledApril 13th, 2021You are here today as a possible participant in a drug research study sponsored by Pfizer Inc. Taking part in this study is voluntary (your choice). The study staff will be available to answer questions before, during, and after the study.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • February 12th, 2022
Contract Type FiledFebruary 12th, 2022You are deciding if you would like to volunteer for a research study. You must read and sign this form before you agree to take part in this study. This form will give you more information about this study and answer questions you may have. Please ask as many questions as you need to before you decide if you want to be in the study. Do not sign this form if you have any questions that have not been answered.
INFORMED CONSENT DOCUMENT AGREEMENT TO BE IN A RESEARCH STUDYInformed Consent Document • July 4th, 2018
Contract Type FiledJuly 4th, 2018Therapy Versus a Smartphone App for Patients Recovering from Total Knee Arthroplasty During the Home-bound Portion of Recovery: Study Protocol for a Randomized Controlled Trial”